Terms: = Colorectal cancer AND MAPK1, MAPK2, 5594, ENSG00000100030, P28482, ERK2, p40, PRKM1, p38, p41, ERT1, p41mapk, PRKM2, P42MAPK, ERK AND Prognosis
193 results:
1. PTPLAD1 Regulates PHB-Raf Interaction to Orchestrate Epithelial-Mesenchymal and Mitofusion-Fission Transitions in colorectal cancer.
Huang ZJ; Li YJ; Yang J; Huang L; Zhao Q; Lu YF; Hu Y; Zhang WX; Liang JZ; Pan J; Pan YL; He QY; Wang Y
Int J Biol Sci; 2024; 20(6):2202-2218. PubMed ID: 38617530
[TBL] [Abstract] [Full Text] [Related]
2. The EIF3H-HAX1 axis increases RAF-MEK-erk signaling activity to promote colorectal cancer progression.
Jin H; Huang X; Pan Q; Ma N; Xie X; Wei Y; Yu F; Wen W; Zhang B; Zhang P; Chen X; Wang J; Liu RY; Lin J; Meng X; Lee MH
Nat Commun; 2024 Mar; 15(1):2551. PubMed ID: 38514606
[TBL] [Abstract] [Full Text] [Related]
3. Role of deubiquitinase JOSD2 in the pathogenesis of esophageal squamous cell carcinoma.
Wang WP; Shi D; Yun D; Hu J; Wang JF; Liu J; Yang YP; Li MR; Wang JF; Kong DL
World J Gastroenterol; 2024 Feb; 30(6):565-578. PubMed ID: 38463028
[TBL] [Abstract] [Full Text] [Related]
4. TIF1γ and SMAD4 regulation in colorectal cancer: impact on cell proliferation and liver metastasis.
Wu Y; Yu B; Ai X; Zhang W; Chen W; Laurence A; Zhang M; Chen Q; Shao Y; Zhang B
Biol Chem; 2024 Apr; 405(4):241-256. PubMed ID: 38270141
[TBL] [Abstract] [Full Text] [Related]
5. Collagen I-induced VCAN/erk signaling and PARP1/ZEB1-mediated metastasis facilitate OSBPL2 defect to promote colorectal cancer progression.
Lin K; Zhao Y; Tang Y; Chen Y; Lin M; He L
Cell Death Dis; 2024 Jan; 15(1):85. PubMed ID: 38267463
[TBL] [Abstract] [Full Text] [Related]
6. KLF7 promotes colon adenocarcinoma progression through the PDGFB signaling pathway.
Zhang Z; Jiang X; Li K; Qiao S; Li M; Mei Y; Ding L; Lv Q; Ding Y; Zhao Y; Lv G; Tan G; Yang H; Li G; Gao X; Liu M
Int J Biol Sci; 2024; 20(1):387-402. PubMed ID: 38164176
[TBL] [Abstract] [Full Text] [Related]
7. Transcriptomic and genomic profiling of multiple primary colorectal cancers reveals intratumor heterogeneity and a distinct immune microenvironment.
Li Y; Li C; Wang Q; Ye YJ; Jiang KW
Int Immunopharmacol; 2024 Jan; 126():111276. PubMed ID: 38016348
[TBL] [Abstract] [Full Text] [Related]
8. A pan-cancer analysis of the MAPK family gene and their association with prognosis, tumor microenvironment, and therapeutic targets.
Qin YY; Yang Y; Ren YH; Gao F; Wang MJ; Li G; Liu YX; Fan L
Medicine (Baltimore); 2023 Nov; 102(45):e35829. PubMed ID: 37960824
[TBL] [Abstract] [Full Text] [Related]
9. Gab2 promotes the growth of colorectal cancer by regulating the M2 polarization of tumor‑associated macrophages.
Gao X; Long R; Qin M; Zhu W; Wei L; Dong P; Chen J; Luo J; Feng J
Int J Mol Med; 2024 Jan; 53(1):. PubMed ID: 37937666
[TBL] [Abstract] [Full Text] [Related]
10. The EMT factor ZEB1 paradoxically inhibits EMT in BRAF-mutant carcinomas.
Sánchez-Tilló E; Pedrosa L; Vila I; Chen Y; Győrffy B; Sánchez-Moral L; Siles L; Lozano JJ; Esteve-Codina A; Darling DS; Cuatrecasas M; Castells A; Maurel J; Postigo A
JCI Insight; 2023 Oct; 8(20):. PubMed ID: 37870961
[TBL] [Abstract] [Full Text] [Related]
11. Cholinergic signaling influences the expression of immune checkpoint inhibitors, PD-L1 and PD-L2, and tumor hallmarks in human colorectal cancer tissues and cell lines.
Kuol N; Godlewski J; Kmiec Z; Vogrin S; Fraser S; Apostolopoulos V; Nurgali K
BMC Cancer; 2023 Oct; 23(1):971. PubMed ID: 37828429
[TBL] [Abstract] [Full Text] [Related]
12. ELK4 Promotes colorectal cancer Progression by Activating the Neoangiogenic Factor LRG1 in a Noncanonical SP1/3-Dependent Manner.
Zhu Z; Guo Y; Liu Y; Ding R; Huang Z; Yu W; Cui L; Du P; Goel A; Liu CY
Adv Sci (Weinh); 2023 Nov; 10(32):e2303378. PubMed ID: 37786278
[TBL] [Abstract] [Full Text] [Related]
13. Tetraspanin 1 regulates papillary thyroid tumor growth and metastasis through c-Myc-mediated glycolysis.
Han J; Xie C; Liu B; Wang Y; Pang R; Bi W; Sheng R; He G; Kong L; Yu J; Ding Z; Chen L; Jia J; Zhang J; Nie C
Cancer Sci; 2023 Dec; 114(12):4535-4547. PubMed ID: 37750019
[TBL] [Abstract] [Full Text] [Related]
14. Crocin exerts anti-tumor effect in colon cancer cells via repressing the JAK pathway.
Yang H; Zhang Y; Zhang D; Qian L; Yang T; Wu X
Eur J Histochem; 2023 Sep; 67(3):. PubMed ID: 37700733
[TBL] [Abstract] [Full Text] [Related]
15. The underlying regulatory mechanisms of colorectal carcinoma by combining Vitexin and Aspirin: based on systems biology, molecular docking, molecular dynamics simulation, and
Chen D; Chen Y; Huang F; Zhang X; Zhou Y; Xu L
Front Endocrinol (Lausanne); 2023; 14():1147132. PubMed ID: 37564983
[TBL] [Abstract] [Full Text] [Related]
16. PDE4DIP contributes to colorectal cancer growth and chemoresistance through modulation of the NF1/RAS signaling axis.
Pan R; Dai J; Liang W; Wang H; Ye L; Ye S; Lin Z; Huang S; Xiong Y; Zhang L; Lu L; Wang O; Shen X; Liao W; Lu X
Cell Death Dis; 2023 Jun; 14(6):373. PubMed ID: 37355626
[TBL] [Abstract] [Full Text] [Related]
17. Autophagy Inhibition Contributes to Apoptosis of PLK4 Downregulation-induced Dormant Cells in colorectal cancer.
Tian X; He Y; Qi L; Liu D; Zhou D; Liu Y; Gong W; Han Z; Xia Y; Li H; Wang J; Zhu K; Chen L; Guo H; Zhao Q
Int J Biol Sci; 2023; 19(9):2817-2834. PubMed ID: 37324947
[TBL] [Abstract] [Full Text] [Related]
18. Prognostic Impact of Ras Mutation on Surgical Strategy in Rectal cancer Patients Undergoing Neoadjuvant Treatment.
Orlandi E; Romboli A; Citterio C; Trubini S; Vecchia S; Palladino MA; Capelli P; Cavanna L
Anticancer Res; 2023 May; 43(5):2015-2024. PubMed ID: 37097644
[TBL] [Abstract] [Full Text] [Related]
19. RFC5, regulated by circ_0038985/miR-3614-5p, functions as an oncogene in the progression of colorectal cancer.
Yao H; Zhou X; Zhou A; Chen J; Chen G; Shi X; Shi B; Tai Q; Mi X; Zhou G; Wang S; Sun J; Yang X; Yang Y; Cao H; Zhou D; Sun L; Yao Y; He S
Mol Carcinog; 2023 Jun; 62(6):771-785. PubMed ID: 36988339
[TBL] [Abstract] [Full Text] [Related]
20. Attenuation of cancer proliferation by suppression of glypican-1 and its pleiotropic effects in neoplastic behavior.
Cheng F; Hansson VC; Georgolopoulos G; Mani K
Oncotarget; 2023 Mar; 14():219-235. PubMed ID: 36944188
[TBL] [Abstract] [Full Text] [Related]
[Next]
